HMS
NVCR icon

Hanseatic Management Services’s NovoCure NVCR Stock Holding History

Hanseatic Management Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-74
Closed -$13K – 166
2020
Q4 		$13K Hold
74
– – 0.03% 115
2020
Q3 		$8K Buy
+74
New +$5.92K 0.02% 149
2020
Q2 		– Sell
-29
Closed -$2K – 220
2020
Q1 		$2K Hold
29
– – ﹤0.01% 188
2019
Q4 		$2K Hold
29
– – ﹤0.01% 222
2019
Q3 		$2K Buy
+29
New +$2.32K ﹤0.01% 192

Other funds holding NVCR

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hanseatic Management Services's NVCR Position: Q1 2021 in Review

Hanseatic Management Services sold out of NovoCure (NVCR) in Q1 2021, closing a stake of 74 shares — an estimated $13K sold.

Hanseatic Management Services first reported a position in NVCR in Q3 2019 and held it in 5 quarters. The position peaked at $13K in Q4 2020. 327 funds tracked by Wall St. Rank hold NVCR as of Q1 2021.

  • Hanseatic Management Services reported no remaining NovoCure position as of Q1 2021 after selling out during the quarter.
  • Hanseatic Management Services sold 74 NovoCure shares in Q1 2021, an estimated $13K.
  • Hanseatic Management Services first reported a position in NovoCure in Q3 2019 and held it in 5 quarters.
  • Hanseatic Management Services's NovoCure position peaked at $13K in Q4 2020.
  • 327 funds tracked by Wall St. Rank held NovoCure as of Q1 2021.

Based on Hanseatic Management Services's 13F filing for Q1 2021, filed 11 May 2021.